Full-Time

Project Engineer 3

Posted on 12/13/2025

PCI Pharma Services

PCI Pharma Services

1-10 employees

Pharmaceutical packaging and contract services

Compensation Overview

$97.3k - $115.5k/yr

+ Annual performance bonus

Rockford, IL, USA

In Person

Category
Biology & Biotech (7)
, , , , , ,
Requirements
  • Bachelor’s degree in Mechanical, Electrical, Chemical, Biomedical Engineering, or related field.
  • 10+ years of experience in project engineering, manufacturing, or construction in regulated industries.
  • Strong understanding of product design, process optimization, and risk mitigation strategies.
  • Excellent communication skills (verbal and written) with the ability to lead and influence.
  • Proficiency in MS Project, AutoCAD, SAP, Excel, and other project management tools.
  • Proven ability to manage multiple priorities in a dynamic environment.
Responsibilities
  • Lead complex engineering projects from initiation through completion, ensuring alignment with quality, cost, and delivery goals.
  • Manage project plans, scopes, timelines, and budgets, ensuring execution excellence at every step.
  • Coordinate with vendors and review project documentation to ensure timely completion and compliance with specifications.
  • Lead projects involving high-speed assembly and packaging of combination medical devices, including auto-injectors.
  • Oversee design transfer and industrialization of drug delivery platforms, ensuring smooth scale-up to commercial production.
  • Apply engineering best practices to optimize manufacturability, reliability, and regulatory compliance.
  • Conduct risk assessments (e.g., FMEA, pFMEA) and lead process improvement initiatives across the product lifecycle.
  • Serve as a mentor to Project Engineers I and II, contributing to a culture of growth and continuous improvement.
  • Act as a technical liaison with customers, regulatory stakeholders, and contractors.
  • Collaborate with Quality, Validation, Manufacturing, and Business Development to ensure cross-functional success.
  • Participate in client-facing meetings, ensuring PCI’s engineering efforts align with evolving partner expectations.
  • Contribute to engaging, transparent discussions during project planning and execution—your voice matters here.
  • Ensure full compliance with all PCI policies and relevant regulations including 21 CFR Part 820, ISO 13485, ISO 11608, and ISO 14971.
  • Lead efforts to implement corrective actions and troubleshoot technical issues.
  • Utilize Lean Six Sigma and operational excellence methodologies to drive efficiency and quality.
Desired Qualifications
  • PMP certification or similar project management credential.
  • Lean Six Sigma certification or equivalent process improvement training.
  • Familiarity with combination products or medical device packaging equipment.
  • Certifications in cGMP, LEED, OSHA, or related disciplines.

PCI Pharma Services offers end-to-end pharmaceutical packaging and related services, including Folding Cartons, Labels, Contract Packaging, Clinical Services, and Brand Protection. It serves as a one-stop source for healthcare product developers and manufacturers, handling carton and label production, packaging operations, clinical services, and brand protection under one roof. The company stands out with eight decades of experience, strict cGMP and ISO compliance, lean manufacturing, ongoing R&D, and comprehensive employee training, security, hygiene, and inspection practices. Its goal is to be a trusted, end-to-end packaging partner that delivers reliable, compliant, and scalable packaging solutions, so clients can focus on their core business.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$4B

Headquarters

Burlington, Canada

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • GLP-1 surge drives demand for PCI's prefilled syringes and autoinjectors.
  • Oncology-CNS pipelines favor PCI's patient-centric drug-device combinations.
  • Bain Capital's $10B valuation fuels $1B capacity expansions through 2028.

What critics are saying

  • San Diego isolator line delays to H1 2028 cede contracts to Lonza.
  • Novo Nordisk's Catalent acquisition slashes external CDMO fill-finish availability.
  • PE backers force divestitures if biotech funding dries post-2025.

What makes PCI Pharma Services unique

  • PCI integrates sterile fill-finish with drug-device assembly for end-to-end injectables.
  • Ajinomoto Althea acquisition adds rare US high-potent ADC sterile filling expertise.
  • AVI systems inspect 75 million vials annually, scaling quality without bottlenecks.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

401(k) Retirement Plan

Health Savings Account/Flexible Spending Account

Company News

BioProcess International
Aug 15th, 2025
Building a better facility: BPI tours PCI manufacturing plant in Bedford

On the last day of June 2025's BIO conference in Boston, Massachusetts, contract development and manufacturing organization (CDMO) PCI Pharma Services bused a crowd of delegates to its manufacturing site in Bedford, New Hampshire where it hosted a tour of its 50,000 square-foot expansion.

Montgomery County
Jul 24th, 2025
PCI Pharma Services Valued at $10B

PCI Pharma Services in Northeast Philadelphia has received a multibillion-dollar investment from Bain Capital and Kohlberg, valuing the company at $10 billion. Kohlberg had previously invested in PCI, while Bain is a new investor. The investment will help PCI expand its services and geographic reach. The company currently operates 38 sites across seven countries and employs over 7,500 people.

JD Supra
Jul 16th, 2025
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital and Kohlberg Invest in PCI Pharma

Healthcare & life sciences Private Equity deal tracker: Bain Capital and Kohlberg invest in PCI Pharma.

FinSMEs
Jul 15th, 2025
PCI Pharma Services Receives Investment from Mubadala, Bain Capital, and Kohlberg

PCI Pharma, a Philadelphia, PA-based contract development and manufacturing organization (CDMO) focused on biotherapies, received an investment from Bain Capital, Kohlberg, and Mubadala Investment Company.

MarketScreener
Jul 14th, 2025
PCI Pharma Services receives new funding

PCI Pharma Services announced it received a new round of funding on July 14, 2025. The funding was co-led by new investor Bain Capital, LP, and returning investor Kohlberg & Company, L.L.C. Additional participation came from returning investors Mubadala Investment Company PJSC and Partners Group Holding AG.

INACTIVE